A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio

BACKGROUND: The prognosis of patients with stage I non-small cell lung cancer (NSCLC) is often uncertain. This study aims to investigate a new prognostic tool to classify stage I NSCLC patients more accurately. METHODS: CD68 and CD163 macrophages were quantified by immunohistochemical analyses of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jiani, Ren, Yijiu, Guo, Haoyue, Mao, Rui, Xie, Huikang, Su, Hang, She, Yunlang, Deng, Jiajun, Yang, Minglei, Han, Biao, Zhang, Yu, Li, Jian, Xie, Dong, Chen, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210133/
https://www.ncbi.nlm.nih.gov/pubmed/32395514
http://dx.doi.org/10.21037/atm.2020.03.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210133/
https://www.ncbi.nlm.nih.gov/pubmed/32395514
http://dx.doi.org/10.21037/atm.2020.03.113

Ejemplares similares